NR566 FINAL EXAM 2026/2027 QUESTIONS
AND CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES 2026/2027
Q&A | INSTANT DOWNLOAD PDF
Core Domains:
• Pharmacokinetics and Pharmacodynamics
• Cardiovascular Pharmacology (Hypertension, Heart Failure, Anticoagulation)
• Endocrine and Metabolic Pharmacology (Diabetes, Thyroid, Osteoporosis)
• Respiratory Pharmacology (Asthma, COPD, Allergic Rhinitis)
• Infectious Disease Pharmacology (Antibiotics, Antivirals, Antifungals)
• Psychiatric and Neurologic Pharmacology (Antidepressants, Antipsychotics,
Anticonvulsants)
• Women's Health and Men's Health Pharmacology
• Pain Management and Substance Use Disorders
• Special Populations (Pediatrics, Geriatrics, Pregnancy)
• Medication Safety, Adverse Drug Reactions, and Drug Interactions
Introduction
The NR566 Advanced Pharmacology for the Care of the Family Final Examination is
a comprehensive assessment designed for graduate nursing and Family Nurse
Practitioner students at Chamberlain University. This exam evaluates your mastery
of pharmacotherapeutic principles across the lifespan, including pharmacokinetics,
,pharmacodynamics, drug classifications, prescribing principles, medication safety,
adverse drug reactions, and evidence-based prescribing practices. The examination
covers content from Weeks 5–8, including pharmacotherapy for eyes, ears, nose,
skin, mental health, neurologic disorders, and special population considerations.
This practice exam features 100 exam-style multiple-choice questions with verified
answers and detailed rationales to reinforce clinical decision-making and
pharmacology knowledge. Successful completion of this practice resource will help
you build confidence and achieve mastery of NR566 competencies for the
2026/2027 academic cycle.
SECTION ONE: QUESTIONS 1–100
1. A 32-year-old woman presents with bacterial sinusitis. She has a history of
anaphylaxis to penicillin. Which antibiotic is safest to prescribe?
• A. Amoxicillin
• B. Azithromycin
• C. Cefuroxime
• D. Amoxicillin-clavulanate
B. Azithromycin
RATIONALE: Patients with severe penicillin allergy (anaphylaxis) should avoid
all beta-lactam antibiotics, including penicillins and cephalosporins. Azithromycin,
a macrolide antibiotic, is safe and effective for bacterial sinusitis in patients with
penicillin allergy.
2. A patient taking warfarin is started on amiodarone. What is the most
important action by the nurse practitioner?
• A. Discontinue warfarin
, • B. Monitor INR closely
• C. Increase warfarin dose
• D. Monitor potassium levels
B. Monitor INR closely
RATIONALE: Amiodarone inhibits warfarin metabolism, increasing bleeding risk.
INR should be monitored closely and warfarin dose adjusted accordingly. This drug
interaction is significant and requires vigilant monitoring.
3. A 22-year-old with asthma presents with wheezing after exercise. Which is
the best immediate treatment?
• A. Oral corticosteroids
• B. Ipratropium bromide
• C. Albuterol
• D. Montelukast
C. Albuterol
RATIONALE: Albuterol is a short-acting beta-agonist (SABA) that provides rapid
bronchodilation within minutes, making it the rescue drug of choice for acute
asthma symptoms and exercise-induced bronchospasm per GINA guidelines.
4. A 55-year-old smoker with chronic cough and dyspnea has an FEV1/FVC
ratio <70%. Which class is first-line for symptom control?
• A. Inhaled corticosteroids alone
• B. Long-acting bronchodilator
• C. Theophylline
• D. Systemic steroids
, B. Long-acting bronchodilator
RATIONALE: GOLD guidelines recommend long-acting bronchodilators (LABAs
or LAMAs) as first-line maintenance therapy for COPD to improve airflow limitation
and reduce symptoms. ICS alone is not first-line for COPD without asthma
features.
5. Which statement best explains why second-generation H₁ antihistamines
(e.g., loratadine, cetirizine, fexofenadine) are preferred for daytime allergic
rhinitis?
• A. They provide significantly stronger H₁ blockade than first-generation
agents
• B. They cross the blood-brain barrier readily, improving CNS symptom control
• C. They have minimal sedation and anticholinergic effects compared with
first-generation agents
• D. They have a shorter half-life, allowing more flexible dosing
C. They have minimal sedation and anticholinergic effects compared with first-
generation agents
RATIONALE: Second-generation H₁ antagonists have low penetration into the
CNS, causing less drowsiness and anticholinergic burden, making them safer for
daytime and older adult use.
6. Which adverse effect is most important to discuss with parents when
prescribing promethazine for motion sickness?
• A. Risk of permanent hearing loss in children
• B. Risk of fatal respiratory depression in children under 2 years
• C. Risk of irreversible extrapyramidal symptoms
AND CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES 2026/2027
Q&A | INSTANT DOWNLOAD PDF
Core Domains:
• Pharmacokinetics and Pharmacodynamics
• Cardiovascular Pharmacology (Hypertension, Heart Failure, Anticoagulation)
• Endocrine and Metabolic Pharmacology (Diabetes, Thyroid, Osteoporosis)
• Respiratory Pharmacology (Asthma, COPD, Allergic Rhinitis)
• Infectious Disease Pharmacology (Antibiotics, Antivirals, Antifungals)
• Psychiatric and Neurologic Pharmacology (Antidepressants, Antipsychotics,
Anticonvulsants)
• Women's Health and Men's Health Pharmacology
• Pain Management and Substance Use Disorders
• Special Populations (Pediatrics, Geriatrics, Pregnancy)
• Medication Safety, Adverse Drug Reactions, and Drug Interactions
Introduction
The NR566 Advanced Pharmacology for the Care of the Family Final Examination is
a comprehensive assessment designed for graduate nursing and Family Nurse
Practitioner students at Chamberlain University. This exam evaluates your mastery
of pharmacotherapeutic principles across the lifespan, including pharmacokinetics,
,pharmacodynamics, drug classifications, prescribing principles, medication safety,
adverse drug reactions, and evidence-based prescribing practices. The examination
covers content from Weeks 5–8, including pharmacotherapy for eyes, ears, nose,
skin, mental health, neurologic disorders, and special population considerations.
This practice exam features 100 exam-style multiple-choice questions with verified
answers and detailed rationales to reinforce clinical decision-making and
pharmacology knowledge. Successful completion of this practice resource will help
you build confidence and achieve mastery of NR566 competencies for the
2026/2027 academic cycle.
SECTION ONE: QUESTIONS 1–100
1. A 32-year-old woman presents with bacterial sinusitis. She has a history of
anaphylaxis to penicillin. Which antibiotic is safest to prescribe?
• A. Amoxicillin
• B. Azithromycin
• C. Cefuroxime
• D. Amoxicillin-clavulanate
B. Azithromycin
RATIONALE: Patients with severe penicillin allergy (anaphylaxis) should avoid
all beta-lactam antibiotics, including penicillins and cephalosporins. Azithromycin,
a macrolide antibiotic, is safe and effective for bacterial sinusitis in patients with
penicillin allergy.
2. A patient taking warfarin is started on amiodarone. What is the most
important action by the nurse practitioner?
• A. Discontinue warfarin
, • B. Monitor INR closely
• C. Increase warfarin dose
• D. Monitor potassium levels
B. Monitor INR closely
RATIONALE: Amiodarone inhibits warfarin metabolism, increasing bleeding risk.
INR should be monitored closely and warfarin dose adjusted accordingly. This drug
interaction is significant and requires vigilant monitoring.
3. A 22-year-old with asthma presents with wheezing after exercise. Which is
the best immediate treatment?
• A. Oral corticosteroids
• B. Ipratropium bromide
• C. Albuterol
• D. Montelukast
C. Albuterol
RATIONALE: Albuterol is a short-acting beta-agonist (SABA) that provides rapid
bronchodilation within minutes, making it the rescue drug of choice for acute
asthma symptoms and exercise-induced bronchospasm per GINA guidelines.
4. A 55-year-old smoker with chronic cough and dyspnea has an FEV1/FVC
ratio <70%. Which class is first-line for symptom control?
• A. Inhaled corticosteroids alone
• B. Long-acting bronchodilator
• C. Theophylline
• D. Systemic steroids
, B. Long-acting bronchodilator
RATIONALE: GOLD guidelines recommend long-acting bronchodilators (LABAs
or LAMAs) as first-line maintenance therapy for COPD to improve airflow limitation
and reduce symptoms. ICS alone is not first-line for COPD without asthma
features.
5. Which statement best explains why second-generation H₁ antihistamines
(e.g., loratadine, cetirizine, fexofenadine) are preferred for daytime allergic
rhinitis?
• A. They provide significantly stronger H₁ blockade than first-generation
agents
• B. They cross the blood-brain barrier readily, improving CNS symptom control
• C. They have minimal sedation and anticholinergic effects compared with
first-generation agents
• D. They have a shorter half-life, allowing more flexible dosing
C. They have minimal sedation and anticholinergic effects compared with first-
generation agents
RATIONALE: Second-generation H₁ antagonists have low penetration into the
CNS, causing less drowsiness and anticholinergic burden, making them safer for
daytime and older adult use.
6. Which adverse effect is most important to discuss with parents when
prescribing promethazine for motion sickness?
• A. Risk of permanent hearing loss in children
• B. Risk of fatal respiratory depression in children under 2 years
• C. Risk of irreversible extrapyramidal symptoms
